We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > sunitinib

News List

Launch of generic oncology medications to improve treatment access in India europeanpharmaceuticalreview
March 04, 2021
GlobalData suggests the recent approval of new generics in oncology should enhance access and adherence to cancer treatment by reducing costs borne by patients.
Launch of generic brands for expensive oncology drugs improves treatment affordability and access in India- GlobalData expresspharma
March 04, 2021
As per India’s National Cancer Registry Programme, the estimated number of people living with cancer in 2020 was around 2.25 million.
Glenmark launches SUTIB (Sunitinib) capsules in India to treat kidney cancer expresspharma
February 18, 2021
The company informs that the drug is priced 96 per cent lower than the innovator brand and reduces the risk of kidney cancer progression by 58 per cent.